Literature DB >> 26366786

Placental Villous Vascularity Is Decreased in Premature Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Sushmita G Yallapragada1, Karen K Mestan1, Hannah Palac2, Nicolas Porta1, Nina Gotteiner3, Aaron Hamvas1, William Grobman4, Linda M Ernst5.   

Abstract

The development of pulmonary hypertension (PH) is a serious complication of bronchopulmonary dysplasia (BPD) among infants born at extremely low gestational ages. Bronchopulmonary dysplasia-associated PH is characterized by persistent pulmonary vasoconstriction, progressive right heart dysfunction, and an increased risk of death. We have shown previously that certain placental vascular lesions are associated with BPD-associated PH. Further evaluation of the villous and vascular morphometry of these placentas is warranted. Using digital image analysis (DIA), we compared villous and vascular morphometric parameters of placentas from infants with and without BPD-associated PH. We conducted a case-control study of placentas from 14 infants born at ≤28 weeks' gestational age (GA). Cases with PH (N=7) and non-PH controls (N=7) were identified using echocardiogram screening at 36 weeks' corrected GA. Central parenchymal sections from each placenta were stained for CD31. Digital image analysis was used to measure vessel and villous capillary number, perimeter, diameter, and area. Mean villous vascularity (number of vessels per villus) was calculated for each patient. Mean vessel and villous number as well as area were similar between the two groups. Villous vascularity was decreased in placentas from infants who ultimately had PH disease compared to non-PH controls (5.5±1.0 vs 7.1±1.6; P<0.05). Placental villous vascularity is decreased in infants with BPD-associated PH. Further studies should assess whether placental morphometric markers may allow clinicians to better predict BPD and provide earlier and more targeted management.

Entities:  

Keywords:  bronchopulmonary dysplasia; fetal growth restriction; placental morphometry; preeclampsia; premature infant; pulmonary hypertension

Mesh:

Substances:

Year:  2015        PMID: 26366786     DOI: 10.2350/15-05-1646-OA.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  8 in total

1.  Cord Blood Biomarkers of Placental Maternal Vascular Underperfusion Predict Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.

Authors:  Karen K Mestan; Nina Gotteiner; Nicolas Porta; William Grobman; Emily J Su; Linda M Ernst
Journal:  J Pediatr       Date:  2017-02-02       Impact factor: 4.406

2.  Placental dysfunction influences fetal monocyte subpopulation gene expression in preterm birth.

Authors:  Abhineet M Sharma; Robert Birkett; Erika T Lin; Linda M Ernst; William A Grobman; Suchitra Swaminathan; Hiam Abdala-Valencia; Alexander V Misharin; Elizabeth T Bartom; Karen K Mestan
Journal:  JCI Insight       Date:  2022-06-08

Review 3.  Recent advances in antenatal factors predisposing to bronchopulmonary dysplasia.

Authors:  Elizabeth Taglauer; Steven H Abman; Roberta L Keller
Journal:  Semin Perinatol       Date:  2018-10-05       Impact factor: 3.300

Review 4.  Placental origins of neonatal diseases: toward a precision medicine approach.

Authors:  Imran N Mir; Rachel Leon; Lina F Chalak
Journal:  Pediatr Res       Date:  2020-12-07       Impact factor: 3.756

Review 5.  Bronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes.

Authors:  Lauren M Davidson; Sara K Berkelhamer
Journal:  J Clin Med       Date:  2017-01-06       Impact factor: 4.241

Review 6.  Novel Strategies to Reduce Pulmonary Hypertension in Infants With Bronchopulmonary Dysplasia.

Authors:  Ahmed El-Saie; Binoy Shivanna
Journal:  Front Pediatr       Date:  2020-05-08       Impact factor: 3.418

7.  Risk Factors and Clinical Outcomes in Preterm Infants with Pulmonary Hypertension.

Authors:  Joseph M Collaco; Gul H Dadlani; Melanie K Nies; Jenny Leshko; Allen D Everett; Sharon A McGrath-Morrow
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

8.  Placental vascular maldevelopment, intrauterine growth restriction, and pulmonary hypertension.

Authors:  Maxwell Mathias; Mireille Bitar; Monica Aldulescu; Robert Birkett; Marta Perez; Karen Mestan
Journal:  Pulm Circ       Date:  2020-11-25       Impact factor: 2.886

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.